Mid-Illinois Hematology Oncology Associates Limited — Normal, Illinois

Mid-Illinois Hematology Oncology Associates Limited is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid-Illinois Hematology Oncology Associates Limited has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hematology Oncology Associates Limited?

Mid-Illinois Hematology Oncology Associates Limited has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hematology Oncology Associates Limited conducted?

Mid-Illinois Hematology Oncology Associates Limited has 7 clinical trials on record, with 4 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Is Mid-Illinois Hematology Oncology Associates Limited accredited by Crixeo Clinical Trials?

Mid-Illinois Hematology Oncology Associates Limited has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Illinois Hematology Oncology Associates Limited?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.